HIV-Associated Heart Disease

NCT00005229 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

To develop natural history data regarding the incidence, clinical course, prognosis, and effects of treatment with anti-viral and immunosuppressive agents on HIV-associated heart disease. A second part of the study evaluated a number of possible mechanisms underlying the development of HIV heart disease.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1988-07-31
Completion
1993-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005229 on ClinicalTrials.gov